Avalo Therapeutics AVTX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $340.23M.
The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avalo Therapeutics's market capitalization?
- Avalo Therapeutics (AVTX) reported market capitalization of $340.23M in Q1 2026.
- How has Avalo Therapeutics's market capitalization changed year-over-year?
- Avalo Therapeutics's market capitalization increased by 298.0% year-over-year, from $85.48M to $340.23M.
- What is the long-term trend for Avalo Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Avalo Therapeutics's market capitalization has grown at a 5.6% compound annual growth rate (CAGR), from $250.44M to $329.31M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.